Showing results (1361-1370 of 5,695) with videos related to

Sort By:
Pageof 570
The Oncologist|October 5, 2026
REVERCE II: A Phase II trial of regorafenib followed by anti-EGFR therapy versus reverse sequencing in refractory metastatic colorectal cancerOluseyi B Abidoye, Fang-Shu Ou, Angela Ulrich, et al.
The Oncologist|October 6, 2026
Real-World Patient-Reported Outcome Comparing Antibody-Drug Conjugates and Conventional Chemotherapy in Metastatic Breast CancerManuela Milani, Francesco Riccetelli, Carla Strina, et al.
The Oncologist|October 5, 2026
Non-Conventional Histologies of Prostate Cancer: From Morphology to Biology-Driven Precision OncologyFabiano Flauto, Giuseppe Neola, Alessia Cimadamore, et al.
The Oncologist|October 22, 2026
From Efficacy to Effectiveness in Gynecologic Oncology: Social Determinants, Therapeutic Transportability, and Biological WeatheringZiwen Zheng, Yamei Chen, Xinyu Yao, et al.
The Oncologist|October 16, 2026
Integrating ctDNA-Based ESR1m Monitoring Into First-Line Care for ER+, HER2- Advanced Breast Cancer: A Consensus WorkflowYara Abdou, Amber Cipriani, Trevor Feinstein, et al.
The Oncologist|October 22, 2026
Real-World Comparative Effectiveness of FOLFOX, FOLFIRI, and CapOx as Second-Line Chemotherapy for Advanced Biliary Tract CancerChun-Yang Chao, Kuan-Yu Tseng, Hsin-Chen Lin, et al.
The Oncologist|October 20, 2026
Hormone Receptor-Positive HER2-Negative Oligometastatic Breast Cancer: prognostic stratification and pattern of progressionJean-Louis Lacaze, Bastien Cabarrou, Thibaut Cassou-Mounat, et al.
The Oncologist|October 20, 2026
Equivocal and Definite Interstitial Lung Abnormalities as Risk Factors for Trastuzumab Deruxtecan-Related Interstitial Lung Disease in Breast CancerTomoaki Nakamura, Naoki Murata, Yukiko Hibino, et al.
The Oncologist|December 8, 2022
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter StudyJian Li, Xinhua Zhang, Yanhong Deng, et al.
The Oncologist|December 9, 2022
Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case SeriesJamie O Brett, Lauren L Ritterhouse, Erik T Newman, et al.
Pageof 570